SEOUL, Aug 16 (Reuters) – South Korea agreed on Tuesday to increase its world well being partnership with the muse arrange by Microsoft Corp (MSFT.O) co-founder and philanthropist Invoice Gates.
The deal got here after Gates arrived in South Korea late on Monday, calling for Seoul to play a much bigger function in world well being and to extend assist.
The settlement contains strengthening personal and public sector cooperation between the Invoice & Melinda Gates Basis and South Korea in initiatives akin to a world well being analysis fund, and stepping up cooperation with well being organisations together with CEPI, South Korea’s international and well being ministries stated in an announcement.
Register now for FREE limitless entry to Reuters.com
The Coalition for Epidemic Preparedness Improvements (CEPI) works with public, personal, philanthropic and civil society organisations to develop vaccines in opposition to future epidemics.
South Korea will even assist to coach 370 folks from lower-income nations in vaccine manufacturing this yr, which will likely be expanded to 2,000 folks per yr beginning 2026, the ministries stated.
“This can be a disaster second for world well being. That is additionally a implausible time for our basis to strengthen partnership with Korea, offering nice concepts for brand new instruments and extra assets to assist these in want,” Gates stated in a speech on the Nationwide Meeting earlier on Tuesday.
Whereas assembly with South Korean Nationwide Meeting Speaker Kim Jin-pyo and different lawmakers, Gates referred to as for rising funding for teams that assist enhance well being circumstances in poor nations and stop pandemics, and requested if South Korea would be capable of scale up its worldwide assist to 0.3% of GDP.
Gates then met President Yoon Suk-yeol, who stated the South Korean authorities wished a cooperative relationship with Gates’ basis to foster high-quality bio-health applied sciences.
Gates additionally met with leaders at SK Bioscience (302440.KS) which acquired $10 million in funding from CEPI to develop its COVID-19 vaccine.
(This story corrects Nationwide Meeting’s official correction of the determine of assist to 0.3% of GDP, not 1.3%, in paragraph 7)
Register now for FREE limitless entry to Reuters.com
Reporting by Joori Roh and Joyce Lee, Further reporting by Hyonhee Shin; Enhancing by Jacqueline Wong and Mark Potter
Our Requirements: The Thomson Reuters Trust Principles.
